Internal Structure of Biomolecular Condensates Linked to Cancer and NeurodegenerationFebruary 26, 2026
DNA & Genetics Astellas, Vir Biotechnology Launch Up-to-$1.7B Prostate Cancer CollaborationBy adminFebruary 26, 20260 Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the prostate cancer candidate VIR-5500, through…
